v3.26.1
Common Stock and Warrants (Tables)
3 Months Ended
Mar. 31, 2026
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Schedule of Warrants outstanding and Exercisable

The following table summarizes the Company’s warrants outstanding and exercisable as of March 31, 2026:

 

   Number of        
   Warrants   Exercise   Expiration
   Outstanding   Price   Date
Investor Warrant   12,852   $8.76   September 18, 2028
2022 Convertible Notes   160,960   $2.38   Various in 2027
2023 Convertible Notes   861,790   $2.38   Various in 2028
Underwriter Warrants   54,370   $2.38   August 8, 2028
Advisory Agreement Warrants   76,512   $2.38   Various in 2029
    1,166,484         
Common Stock [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Schedule of Warrant Activity for Common Stock

The following is a summary of warrant activity for common stock during the three months ended March 31, 2026 and year ended December 31, 2025:

  

   Number of   Weighted-Avg.   Weighted-Avg. 
   Warrants for   Exercise   Remaining 
   Common Stock   Price   Contractual Life 
Outstanding as of January 1, 2025   2,642,530   $2.41    2.93 
Exercised   (1,263,006)   1.82    2.12 
Outstanding as of December 31, 2025   1,379,524    2.44    2.26 
Exercised   (213,040)   2.38    1.94 
Outstanding as of March 31, 2026   1,166,484   $2.45    2.04